Study guide
25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery
NBCRNA CRNA Certified Registered Nurse Anesthetist NCE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology
1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders
2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems
2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms
3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives
3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology
4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics
4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics
5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies
5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout
6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators
6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging
7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation
7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways
8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety
8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety
9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation
9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication
10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring
10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies
11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms
11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)
12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA
12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm
13 Chapter 13: Regional Anesthesia: Neuraxial Blocks
13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma
14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance
14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols
15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice
15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives
16 Chapter 16: Obstetric & Gynecologic Anesthesia
16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient
17 Chapter 17: Pediatric Anesthesia
17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm
18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia
18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols
19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia
19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction
20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia
20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation
21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology
21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements
22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology
22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices
23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures
23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases
24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control
24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure
25 Chapter 25: Neurosurgical Subspecialty Procedures
25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy
26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia
26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery
27 Chapter 27: Orthopedic & Extremity Anesthesia
27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block
28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy
28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia
29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients
29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient
25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery
Key Takeaways Explain This Topic AI
Acromegaly produces difficult mask ventilation and difficult intubation with an unreliable Mallampati score, and glottic or subglottic narrowing requires a smaller endotracheal tube than body size suggests.
Nasal mucosal vasoconstrictor injection at the start of the case causes abrupt hypertension and tachycardia, after which transsphenoidal surgery is relatively unstimulating.
Postoperative diabetes insipidus is recognized by urine output above 200 to 250 mL/h with urine specific gravity below 1.005 and rising serum sodium, and treated with desmopressin.
The triphasic response is diabetes insipidus, then an SIADH phase with hyponatremia around days 5 to 10, then permanent diabetes insipidus, so continuing DDAVP through the second phase causes dangerous hyponatremia.
Positive pressure mask ventilation, CPAP, and nasogastric tubes are avoided after transsphenoidal surgery because a skull base defect allows pneumocephalus and meningitis.
Last updated: August 2026
Why This Topic Matters on the NCE
Transsphenoidal hypophysectomy is its own named sub-topic (IV.A.3.b.iv) on the content outline. It is a compact exam topic because a single case connects three domains at once: a difficult airway created by an endocrine disease, an intracranial procedure with vascular catastrophe potential, and a postoperative endocrine emergency.
1. What the Surgery Is
An endoscopic or microscopic approach through the nose and sphenoid sinus to the sella turcica for resection of a pituitary adenoma. Indications:
- Tumor Hormone Systemic disease
- Prolactinoma Prolactin Amenorrhea, galactorrhea; usually treated medically with dopamine agonists first
- Somatotroph adenoma Growth hormone Acromegaly
- Corticotroph adenoma ACTH Cushing disease
- Thyrotroph adenoma TSH Central hyperthyroidism (rare)
Nonfunctioning adenoma None Mass effect: bitemporal hemianopsia from optic chiasm compression, headache, hypopituitarism
Document the visual field defect preoperatively — bitemporal hemianopsia is the classic sign of chiasmal compression, and its change is a postoperative endpoint.
2. Acromegaly: The Airway Problem
Acromegaly is the highest-yield airway topic in this section and one of the classic difficult airways on the NCE.
Feature Consequence
Macroglossia, prognathism, thickened pharyngeal and laryngeal soft tissue Difficult mask ventilation and difficult direct laryngoscopy
Subglottic and glottic narrowing, vocal cord thickening Use a smaller endotracheal tube than the patient's body size suggests ; hoarseness suggests recurrent laryngeal nerve involvement or glottic stenosis and predicts a difficult tube passage
- Hypertrophied nasal turbinates Nasal intubation is relatively contraindicated and risks bleeding
- Obstructive sleep apnea in a majority Sensitivity to sedatives; postoperative airway obstruction
- Mallampati score is unreliable in acromegaly Do not be reassured by a favorable score
Ulnar artery flow may be compromised by soft tissue overgrowth Perform an Allen test or use ultrasound before radial arterial cannulation
Acromegaly also brings cardiomyopathy, hypertension, left ventricular hypertrophy, diabetes mellitus, and skeletal changes . Plan for awake fiberoptic or video-laryngoscopic intubation when airway findings are severe.
Cushing disease contributes a different set: central obesity, hypertension, hyperglycemia, hypokalemic metabolic alkalosis , osteoporosis with fracture risk on positioning, thin friable skin requiring meticulous padding and tape technique, proximal myopathy, and obstructive sleep apnea.
- 3. Intraoperative Management
- Setup
Oral RAE or a reinforced oral tube taped to the left corner of the mouth, away from the surgical field.
A throat pack is usually placed to prevent blood accumulating in the stomach; it must be documented on the count and its removal explicitly confirmed before extubation.
Meticulous eye protection — the surgical field is immediately adjacent and image-guidance frames are close to the face.
Head slightly extended and turned, often in pins or a horseshoe; frequently image-guided navigation or fluoroscopy is used.
Access to the airway is limited once draped.
The vasoconstrictor response
The surgeon injects and packs the nasal mucosa with a vasoconstrictor — commonly oxymetazoline, phenylephrine, or epinephrine-containing local anesthetic, and historically cocaine 4 percent . Systemic absorption from the highly vascular nasal mucosa produces abrupt hypertension and tachycardia , and cocaine adds dysrhythmia risk. Anticipate this; treat with a short-acting agent and avoid beta-blocker monotherapy after cocaine because of unopposed alpha stimulation.
The rest of the case
Apart from the initial injection, transsphenoidal surgery is relatively unstimulating , so anesthetic depth must be titrated down to avoid an overly deep anesthetic followed by a hypertensive emergence.
Intraoperative complications
Complication Recognition and response
Internal carotid artery injury Catastrophic hemorrhage in a confined field; massive transfusion, packing, urgent endovascular intervention
- Cavernous sinus injury Venous bleeding; cranial nerve III, IV, V1, V2, and VI are at risk
- Venous air embolism Head-up position with open venous sinuses; monitor end-tidal CO2 for a sudden fall
- CSF leak The surgeon may ask for a Valsalva maneuver or sustained positive airway pressure to test the repair
- Diabetes insipidus Usually postoperative, occasionally begins intraoperatively
- 4. Postoperative Priorities
- Diabetes insipidus
Posterior pituitary or stalk manipulation causes ADH deficiency. Recognize it by:
- Polyuria greater than 200 to 250 mL/h for consecutive hours
- Dilute urine : specific gravity below 1.005, urine osmolality below 200 mOsm/kg
- Rising serum sodium and serum osmolality
Treatment is desmopressin (DDAVP) with careful matching of fluid replacement to losses and frequent electrolyte measurement.
The triphasic response is a classic exam item: an initial diabetes insipidus phase lasting hours to days, followed by an SIADH phase with hyponatremia from release of stored ADH from degenerating neurons around days 5 to 10, followed by permanent diabetes insipidus. Treating the second phase as though it were still the first causes dangerous hyponatremia.
Adrenal insufficiency
Corticotroph deficiency after resection, and preexisting hypopituitarism, both require perioperative stress-dose glucocorticoid coverage (commonly hydrocortisone) with an endocrine plan for taper and testing.
Airway management after extubation
Nasal packing makes the patient an obligate mouth breather ; obstruction is a real risk, especially with acromegaly and obstructive sleep apnea.
Avoid positive pressure mask ventilation, CPAP, and noninvasive ventilation postoperatively where a skull base defect exists — forcing air across the repair causes pneumocephalus and can seed meningitis. This restriction is a serious problem in a patient with obstructive sleep apnea and must be planned for with the surgical team.
Avoid nasogastric tube placement.
Aim for smooth extubation without coughing or bucking , which stresses the sellar repair.
Monitor for CSF rhinorrhea, and check visual fields and cranial nerve function.
Exam Traps
Use a smaller endotracheal tube in acromegaly , and treat a hoarse acromegalic patient as having glottic stenosis until proven otherwise.
Mallampati is unreliable in acromegaly.
Avoid nasal intubation and nasogastric tubes in transsphenoidal surgery.
No CPAP postoperatively with a skull base defect — pneumocephalus.
The triphasic response means the hyponatremic phase around days 5 to 10 must not be treated with continued DDAVP.